...
首页> 外文期刊>OncoTargets and therapy >MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2
【24h】

MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2

机译:MicroRNA-148b通过靶向转移相关基因2抑制鼻咽癌细胞的增殖,迁移和侵袭

获取原文

摘要

Purpose: MicroRNAs (miRNAs) play important roles in tumorigenesis and metastasis by regulating genes expression. MiRNA-148b (miR-148b) had been reported to inhibit tumor progression in some kinds of cancers, but the functions of miR-148b in nasopharyngeal carcinoma (NPC) remain largely unknown. The aim of this study was to investigate the functional role of miR-148b in NPC. Methods: Expression of miR-148b in NPC tissues and cell lines was detected by quantitative reverse transcription polymerase chain reaction. MiR-148b was overexpressed in CNE2 and C666-1 cells by miR-148b mimic transfection. The effects of miR-148b on cell proliferation, migration, and invasion were determined by colony formation assays, cell viability assays, and transwell assays. The target gene of miR-148b was investigated by luciferase assays, and the rescue experiment was performed. Results: MiR-148b was downregulated in NPC tissues and cell lines. Ectopic miR-148b expression significantly inhibited proliferation, migration, and invasion of CNE2 and C666-1 cells. We identified that metastasis-associated gene 2 ( MTA2 ) is a direct target of miR-148b. Rescue experiment demonstrated that the tumor-suppressive effects of miR-148b on C666-1 cell were partly reversed by restoration of MTA2 expression. Moreover, miR-148b expression was negatively related to mRNA level of MTA2 in NPC tissues. Conclusion: Our findings elucidate that miR-148b negatively regulates the growth, migration, and invasion of NPC cells, at least in part, by targeting MTA2. The present study indicates that miR-148b is a potential therapeutic agent for NPC.
机译:目的:MicroRNA(miRNA)通过调节基因表达在肿瘤发生和转移中发挥重要作用。据报道,miRNA-148b(miR-148b)在某些类型的癌症中可抑制肿瘤的进展,但miR-148b在鼻咽癌(NPC)中的功能仍然未知。这项研究的目的是调查miR-148b在NPC中的功能作用。方法:通过定量逆转录聚合酶链反应检测miR-148b在NPC组织和细胞系中的表达。 miR-148b模拟转染可在CNE2和C666-1细胞中过表达MiR-148b。 miR-148b对细胞增殖,迁移和侵袭的影响通过集落形成测定,细胞活力测定和transwell测定来确定。通过荧光素酶测定研究miR-148b的靶基因,并进行了拯救实验。结果:MiR-148b在NPC组织和细胞系中被下调。异位miR-148b表达显着抑制CNE2和C666-1细胞的增殖,迁移和侵袭。我们确定,转移相关基因2(MTA2)是miR-148b的直接目标。救援实验表明,通过还原MTA2的表达,miR-148b对C666-1细胞的肿瘤抑制作用被部分逆转。此外,miR-148b表达与NPC组织中MTA2的mRNA水平呈负相关。结论:我们的发现阐明,miR-148b至少部分地通过靶向MTA2负调控NPC细胞的生长,迁移和侵袭。本研究表明,miR-148b是NPC的潜在治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号